title: IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma.
abstract: OBJECTIVE
  To determine the value of IL-10 measurement in aqueous humor (AH) for screening in primary intraocular lymphoma (PIOL).
  
  
  METHODS
  One hundred consecutive diagnostic or therapeutic vitrectomies were performed in patients with uveitis. During surgery, 100 microL of both AH and pure vitreous was taken. IL-10 levels were determined with a standard quantitative sandwich enzyme immunoassay technique. Patients were distributed in two groups: 51 patients with proven PIOL, 108 patients with uveitis divided into 74 with uveitis of proven etiology and 34 with idiopathic uveitis. Groups were compared by ANOVA and the Tukey-Kramer test or nonparametric Wilcoxon test. Distributions were compared by using the chi(2) test. Segmentation was derived from the ROC curves by choosing a tradeoff between sensitivity and specificity.
  
  
  RESULTS
  In patients with PIOL, IL-10 mean values were 2205.5 pg/mL (median: 1467 pg/mL) in the vitreous and 543.4 pg/mL (median: 424 pg/mL) in AH. In patients with uveitis (idiopathic and diagnostic uveitis), mean values were 26.6 pg/mL (median: 8 pg/mL) in the vitreous, and 21.9 pg/mL (median: 8 pg/mL) in AH. IL-10 mean values were significantly different between patients with PIOL and patients with uveitis (P < 10(-3)). The areas under the curves were 0.989 and 0.962 for vitreous and AH, respectively. A cutoff of 50 pg/mL in the AH was associated with a sensitivity of 0.89 and a specificity of 0.93. In the vitreous, a cutoff value of 400 pg/mL yielded a specificity of 0.99 and a sensitivity of 0.8.
  
  
  CONCLUSIONS
  Diagnosis of PIOL is often made months or years after the initial onset of ocular symptoms. Cytology remains the gold standard for diagnosis. However, measurement of IL-10 in the AH is a good screening test to reduce diagnostic delays.
authors.affiliation: Department of Ophthalmology, Hopital Pitié-Salpêtrière, Paris, France. nathalie.cassoux@psl.aphp.fr
authors.forename: Nathalie
authors.initials: N
authors.lastname: Cassoux
authors.forename: Alain
authors.initials: A
authors.lastname: Giron
authors.forename: Bahram
authors.initials: B
authors.lastname: Bodaghi
authors.forename: Thi H C
authors.initials: TH
authors.lastname: Tran
authors.forename: Sylvie
authors.initials: S
authors.lastname: Baudet
authors.forename: Fréderic
authors.initials: F
authors.lastname: Davy
authors.forename: Chi C
authors.initials: CC
authors.lastname: Chan
authors.forename: Phuc
authors.initials: P
authors.lastname: Lehoang
authors.forename: Hélène
authors.initials: H
authors.lastname: Merle-Béral
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001082:Aqueous Humor / Q000378:metabolism*; D002648:Child; D005134:Eye Neoplasms / Q000175:diagnosis / Q000378:metabolism*; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D016753:Interleukin-10 / Q000378:metabolism*; D016393:Lymphoma, B-Cell / Q000175:diagnosis / Q000378:metabolism*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D012372:ROC Curve; D012680:Sensitivity and Specificity; D014605:Uveitis / Q000378:metabolism; D014821:Vitrectomy; D014822:Vitreous Body / Q000378:metabolism* / Q000473:pathology
chemical_list: C508609:IL10 protein, human; D016753:Interleukin-10